FDA Grants Ampio Pharma Approval to Begin Phase 1 Trial in COVID-19 Patients
Source: Streetwise Reports  (6/19/20)
Ampio Pharmaceuticals' shares traded higher after the company reported that the FDA cleared the firm to proceed with human trials of its Investigative New Drug application for intravenous AmpionTM for treatment in COVID-19 affected patients on supplemental oxygen. More >

Junior Royalty Company Wants to Be a Major
Source: Streetwise Reports  (6/18/20)
Ely Gold aims to emulate the early years of today's royalty majors. More >

Gold Explorer Commences Preparations for IP Survey on Val-d'Or, Quebec Gold Property
Source: Streetwise Reports  (6/18/20)
Black Tusk Resources reported that it has begun preparations for a 3D IP Survey on the McKenzie East Gold Project. More >

Blackrock Gets a Chance to Become a Hero
Source: Bob Moriarty for Streetwise Reports  (6/18/20)
Bob Moriarty of 321gold awaits results from this explorer's drill program. More >

Alpine Immune Shares Soar 160% on Global Option and License Agreement with AbbVie
Source: Streetwise Reports  (6/18/20)
Shares of Alpine Immune Sciences set a new 52-week high after the company reported that it entered into an exclusive worldwide option and license agreement with AbbVie Inc. to develop and commercialize ALPN-101. More >

Lots Going On at Russian Silver-Copper Project
Source: Peter Epstein for Streetwise Reports  (6/18/20)
Azarga Metals CEO Michael Hopley speaks with Peter Epstein of Epstein Research about exploration at the company's silver-copper project in Siberia and the resource estimate that will be released in the next few weeks. More >

Regenerative Medicine Firm Reports Early Results from COVID-19 Trials
Source: Streetwise Reports  (6/17/20)
Pluristem Therapeutics' coronavirus clinical studies and financing are discussed in a Dawson James report. More >

Biopharma Launches Trial Testing Nitric Oxide as COVID-19 Treatment
Source: Streetwise Reports  (6/17/20)
The design, timeline and takeaways of Beyond Air's study are presented in a ROTH Capital Partners report. More >

Gold Explorer to Conduct 3D IP Survey at Quebec Gold Property
Source: Streetwise Reports  (6/17/20)
Black Tusk Resources reported that it has commissioned a 3D Induced Polarization Survey on the McKenzie East Gold Project. More >

Alkaline, Flavored and CBD Infused Bottled Water Maker Posts Record Growth in Q4/20
Source: Streetwise Reports  (6/17/20)
The Alkaline Water Co. shares traded 20% higher after the company reported that it posted a 51% growth in year-over-year revenue in Q4/20. More >

Benchmark's Serious 50,000-Meter Drill Program
Source: Bob Moriarty for Streetwise Reports  (6/17/20)
Bob Moriarty of 321gold discusses a company with a project in northern British Columbia that has "exceptional" past drill results. More >

Biotech Makes 'Significant Progress' Creating Highly Accurate COVID-19 Antibody Test
Source: Streetwise Reports  (6/17/20)
ProMIS Neurosciences states that the current version of the ProMIS-BCNI assay achieves 99.9% sensitivity and 99.5% specificity for SARS CoV-2, the coronavirus causing COVID-19. More >

The V-Recovery and Beyond
Source: McAlinden Research for Streetwise Reports  (6/17/20)
Joseph J. McAlinden of McAlinden Research Partners outlines his firm's view of what post-pandemic recovery will look like for various markets and explains why the firm is in a minority that foresees a V-shaped recovery. More >

Gold Company Begins Exploring Quebec Property
Source: Streetwise Reports  (6/16/20)
X-Terra Resources began its 2020 exploration program its Troilus East property on northern Quebec's Frotet-Evans greenstone belt. More >

Clean Tech Firm Joins with Electric-Powered Motorcycles Developer to Advance Powertrain Efficiency
Source: Streetwise Reports  (6/16/20)
Exro Technologies reported it will be collaborating with Zero Motorcycles to develop advanced coil drive powertrains for the electric motorcycle market. More >

Royalty Company to Sell Claims on Nevada Property
Source: Streetwise Reports  (6/16/20)
Ely Gold Royalties will retain a 2% net smelter returns royalty on any future production there. More >

Explorer to Start Drilling at Red Lake Project This Week
Source: Streetwise Reports  (6/16/20)
Initially, Nexus Gold plans to drill over 1,000 meters to test several targets for mineralization potential. More >

David Smith: 'Common Sense 2.0' Is a Call to Action to Hold Government Accountable
Source: Maurice Jackson for Streetwise Reports  (6/16/20)
David Smith of The Morgan Report tells Maurice Jackson of Proven and Probable what he thinks about the current financial state of America, ways investors can protect themselves from the vagaries of modern times—including reading "Common Sense 2.0"—and mentions a few resource companies he finds worthwhile. More >

Eli Lilly Trades Up 15% on Positive Phase 3 Breast Cancer Trial Results
Source: Streetwise Reports  (6/16/20)
Eli Lilly shares set a new 52-week high price after the company reported that its Verzenio® (abemaciclib) significantly reduced the risk of cancer returning in people with high risk HR+, HER2- early breast cancer. More >

Adrian Day: Merger Lays a Firm Foundation for Future Growth
Source: Adrian Day for Streetwise Reports  (6/16/20)
Fund manager Adrian Day discusses why he likes the proposed merger of Evrim Resources with Renaissance Gold, plus he names some companies on his buy list. More >

Digital Health Company Growth Continues with Acquisition of BC Medical Clinic
Source: Streetwise Reports  (6/15/20)
CloudMD reported that it has signed a binding agreement to acquire a British Columbia medical clinic with 12 on-staff physicians in a cash and stock deal valued at CA$700,000. More >

Life Sciences Firm Expands Collaboration Efforts with Major U.S. University to Develop Psilocybin-Based Medicines
Source: Streetwise Reports  (6/15/20)
Revive Therapeutics Ltd. reported it has expanded its research partnership for novel formulation development and clinical research of psilocybin with the University of Wisconsin-Madison. More >

A Battle for the Ages
Source: Michael Ballanger for Streetwise Reports  (6/15/20)
Sector expert Michael Ballanger critiques the latest news and moves in the stock and precious metals markets. More >

Edesa Shares Double Upon Gaining Approval to Initiate Phase 2/3 COVID-19 Study
Source: Streetwise Reports  (6/15/20)
Shares of Edesa Biotech traded more than 100% higher after the company reported that it had received regulatory approval from Health Canada to initiate a Phase 2/3 study of its investigational drug EB05 in COVID-19. More >

Technical Analyst Update on Black Tusk Resources
Source: Clive Maund for Streetwise Reports  (6/15/20)
Technical analyst Clive Maund charts the explorer and discusses recent trading in the stock. More >